SCHEMBL5869760

SCHEMBL5869760

CC(C)CC(NCc1ccc(C(=O)O)cc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
LMNA P02545 1/20 0.51
CTSK P43235 1/20 0.51
KMT2A Q03164 2/20 0.50
FOLH1 Q04609 2/20 0.48
KDM4E B2RXH2 1/20 0.47
MMP1 P03956 1/20 0.47
MMP3 P08254 1/20 0.47
MMP9 P14780 1/20 0.47
GRN P28799 1/20 0.46
SORT1 Q99523 1/20 0.46
CA2 P00918 2/20 0.45
CA1 P00915 1/20 0.45
EPHX2 P34913 2/20 0.44
NR1H4 Q96RI1 2/20 0.44
PSMB5 P28074 1/20 0.44
ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8255500 1.00 ALDH1A1 (0.51) ALDH1A1LMNACTSKKMT2AFOLH1
SCHEMBL17833228 0.85 PSMB5 (0.57) ALDH1A1LMNACTSKKMT2APSMB5
SCHEMBL3451636 0.85 PSMB5 (0.57) ALDH1A1LMNACTSKKMT2APSMB5
SCHEMBL3451593 0.85 PSMB5 (0.57) ALDH1A1LMNACTSKKMT2APSMB5
SCHEMBL5172068 0.84 MME (0.56) ALDH1A1LMNACTSKMMP1MMP3
SCHEMBL27723663 0.84 ITGB1 (0.55) ALDH1A1LMNACTSKFOLH1GRN
SCHEMBL27723661 0.84 ITGB1 (0.55) ALDH1A1LMNACTSKFOLH1GRN
SCHEMBL560722 0.84 FPR2 (0.57) ALDH1A1LMNACTSKFOLH1GRN
SCHEMBL560721 0.84 FPR2 (0.57) ALDH1A1LMNACTSKFOLH1GRN
SCHEMBL4703394 0.84 CTSK (0.69) ALDH1A1LMNACTSKFOLH1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045532-B2 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-05-16 US disclosed
US-6632830-B1 Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder MILLENNIUM PHARMACEUTICALS, INC. 2003-10-14 US disclosed